Skip to content

The Canadian Cancer Society’s annual Daffodil Campaign ignites hope through research innovation

Challenge Grants fund research projects aimed at making a real difference in the lives of people with cancer.

MONTREAL, March 31, 2022 /CNW/ – Every April, the Canadian Cancer Society’s (CCS) Daffodil Campaign raises vital funds to save lives and improve the quality of life for people with cancer. cancer. The Daffodil Campaign spreads hope in our communities and helps support Canadian cancer researchers who are working to transform cancer care and improve the cancer experience for those affected. This year, the CCS celebrates the awarding of 46 Challenge Grants totaling $19.7 million, which will be used to fund the most promising research projects aimed at solving a complex research challenge.

“Nothing has ever reduced the devastating impact of cancer like research does,” said CCS President and CEO Andrea Seale. The best way to help people who will be diagnosed with cancer in their lifetime, which is almost half of the people in the country, is to provide more support for innovative and meaningful research projects that improve how to prevent, detect and treat cancer, and how to live during and after the disease. Funds raised through this year’s Daffodil Campaign will support the brightest researchers in the field. »

The CCS Challenge Grants program supports Canadian projects across the cancer spectrum from a variety of fields. The projects aim to find a clear solution to the challenge chosen by each research team and will have immediate benefits or lay the foundations for a major long-term breakthrough. They were chosen with the help of more than 100 scientific experts, people with cancer, survivors and caregivers, and the grants were generously funded by the Lotte & John Hecht Memorial Foundation.

The selected research projects notably address the following topics: a new sugar-based dye to detect breast cancer; viruses to prevent colorectal cancer; a blood test to determine the spread of cancer; an app to help young adult cancer survivors; oral cancer detection supported by artificial intelligence; the barriers and inequities black women face in breast cancer care; luminous nanoparticles to increase the precision of surgeries; the link between diet and the effectiveness of immunotherapy; and more.

“We could not award Challenge Grants without the generosity of our donors. The effects of COVID-19 have been felt in our fundraising. We aspire to return to our pre-pandemic levels of research investment to continue to bring hope to people with cancer. We therefore urge people across the country to support the Daffodil Campaign to enable us to invest in more innovative research projects to address the greatest challenges posed by cancer,” added Andrea Seale.

In the coming year, the CCS plans to fund several innovative research projects that address the primary needs of people with cancer, with the goal of saving lives and improving the quality of life of those living with cancer. sickness. The cancers for which the survival rate is the lowest will be the subject of particular attention.

The 2022 Daffodil Campaign marks the return of in-person fundraising for the CCS, after a two-year hiatus caused by the pandemic. Donations will be accepted at more than 100 contactless payment points in various businesses and pharmacies, including Provigo, Maxi, Jean Coutu, Brunet, Pharmasave and London Drugs. The CCS encourages people across the country to rally around the symbol of the daffodil and bring hope to those living with cancer.

To learn more or to donate, visit

Health Index publication: 2022-03-31 – Number of visits since publication: 14091

To read on Health Index:

Leave a Reply

Your email address will not be published.